Deal Announcement
goetzpartners advised Mipharm S.p.A.
Due Diligence
Healthcare and Life Sciences
Transaction
März 2022
goetzpartners advised
Mipharm S.p.A. with a
Commercial Vendor Due Diligence
on its sale
value not disclosed
Scroll down
Kontakt
Giovanni Calia
Due Diligence, Value Creation and Exit Readiness, Portfolio Strategy and Buy & Build, Principal Investors and Private Equity
Weitere TransaktionenDas könnte Sie auch interessieren...
Juni 2024
Fortlane Partners advised
founders and management with a
Commercial Vendor Due Diligence
on the sale of Arsipa GmbH
value not disclosed
März 2023
goetzpartners advised
Polygon S.p.A. with a
Commercial Vendor Due Diligence
on its sale
value not disclosed
Mai 2022
goetzpartners advised
Clonit S.r.l. with a
Commercial Vendor Due Diligence
on its sale
value not disclosed
Mai 2022
goetzpartners advised
Insec Equity Partners SGR S.p.A. with a
Commercial Vendor Due Diligence
on the sale of Plurima S.p.A.
value not disclosed
November 2020
goetzpartners advised
Silverfleet Capital with a
Commercial Vendor Due Diligence
on the sale of 7days
value not disclosed